Abstract
Paclitaxil is a non-water soluble anti-cancer drug with problems of solvent related toxicities due to use of ethanol and polyethylated castor-oil for administration. Several formulations have been prepared to overcome the solubility problem and the present work describes one of such possibility of the preparation of water-soluble paclitaxil nanoparticles by Emulsion-solvent evaporation technique. The paclitaxil nanoparticles were prepared by nanoemulsification using human serum albumin as polymer. The prepared nanoparticles were evaluated by stability studies, encapsulating efficiency, in-vitro toxicity studies. It aims to verify the in vivo capacity of the formed nanoparticles to reduce the toxicity, which would have been caused by the conventional Cremophor EL. The prepared nanoparticles were soluble in 0.9%NaCl, showed better encapsulating efficiency and the reconstituted solution was stable for more than 24 hrs. In-vivo abnormal toxicity studies were carried out on albino mice and guinea pig and showed that the paclitaxilnanoparticles formed had no toxicity as compared to Cremophor EL.
Keywords: Nanoparticles, albumin, reduced toxicity, paclitaxil, homogenization, bio-degradable, stability, lyophilization
Current Bioactive Compounds
Title: Preparation of Water-Soluble Albumin Loaded Paclitaxil Nanoparticles Using Emulsion-Solvent Evaporation Technique
Volume: 4 Issue: 1
Author(s): A. Anil Yadav and Shanthi Vadali
Affiliation:
Keywords: Nanoparticles, albumin, reduced toxicity, paclitaxil, homogenization, bio-degradable, stability, lyophilization
Abstract: Paclitaxil is a non-water soluble anti-cancer drug with problems of solvent related toxicities due to use of ethanol and polyethylated castor-oil for administration. Several formulations have been prepared to overcome the solubility problem and the present work describes one of such possibility of the preparation of water-soluble paclitaxil nanoparticles by Emulsion-solvent evaporation technique. The paclitaxil nanoparticles were prepared by nanoemulsification using human serum albumin as polymer. The prepared nanoparticles were evaluated by stability studies, encapsulating efficiency, in-vitro toxicity studies. It aims to verify the in vivo capacity of the formed nanoparticles to reduce the toxicity, which would have been caused by the conventional Cremophor EL. The prepared nanoparticles were soluble in 0.9%NaCl, showed better encapsulating efficiency and the reconstituted solution was stable for more than 24 hrs. In-vivo abnormal toxicity studies were carried out on albino mice and guinea pig and showed that the paclitaxilnanoparticles formed had no toxicity as compared to Cremophor EL.
Export Options
About this article
Cite this article as:
Yadav Anil A. and Vadali Shanthi, Preparation of Water-Soluble Albumin Loaded Paclitaxil Nanoparticles Using Emulsion-Solvent Evaporation Technique, Current Bioactive Compounds 2008; 4 (1) . https://dx.doi.org/10.2174/157340708784533410
DOI https://dx.doi.org/10.2174/157340708784533410 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
Call for Papers in Thematic Issues
Antioxidants: Unveiling their Power in Health and Disease
Antioxidants have captured significant interest for decades due to their potential role in preventing chronic diseases. These molecules combat free radicals and unstable molecules that damage cells and contribute to the development of conditions like metabolic diseases, heart disease, cancer, and neurodegenerative diseases. This thematic issue will explore the cutting-edge ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Quinquennial Review of Potent LSD1 Inhibitors Explored for the
Treatment of Different Cancers, with Special Focus on SAR Studies
Current Medicinal Chemistry Advances in Lentiviral Vectors: A Patent Review
Recent Patents on DNA & Gene Sequences Diterpenoids- Potential Chemopreventive and Chemotherapeutic Agents in Leukemia
Current Pharmaceutical Biotechnology New Biomarkers for Colon Cancer Diagnosis: A Review of Recent Patents
Recent Patents on Biomarkers Meet Our Editorial Board Member
Recent Patents on Anti-Cancer Drug Discovery Cytoplasmic CXCR4 High-Expression Exhibits Distinct Poor Clinicopathological Characteristics and Predicts Poor Prognosis in Triple-Negative Breast Cancer
Current Molecular Medicine MicroRNAs: A Novel Therapeutic Target for Schizophrenia
Current Pharmaceutical Design Nitrosative Stress as a Mediator of Apoptosis: Implications for Cancer Therapy
Current Pharmaceutical Design Molecular Mechanism of Aniline Induced Spleen Toxicity and Neuron Toxicity in Experimental Rat Exposure: A Review
Current Neuropharmacology Non-Invasive Approaches to Visualize the Endothelin Axis In Vivo Using State-of-the-Art Molecular Imaging Modalities
Mini-Reviews in Medicinal Chemistry Potential Crossreactivity of Human Immune Responses Against HCMV Glycoprotein B
Current Drug Discovery Technologies Aldehyde Dehydrogenase as a Marker for Stem Cells
Current Stem Cell Research & Therapy Nutritional and Therapeutic Potential of Spirulina
Current Pharmaceutical Biotechnology Alkylphospholipids are Signal Transduction Modulators with Potential for Anticancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Invasive aspergillosis: adjunctive combination therapy
Mini-Reviews in Medicinal Chemistry Heteroaromatic Pim Kinase Inhibitors Containing a Pyrazole Moiety
Recent Patents on Anti-Cancer Drug Discovery The State-of-Art in Angiogenic Properties of Latex from Different Plant Species
Current Angiogenesis (Discontinued) Chronic Myelogenous Leukemia
Current Cancer Therapy Reviews Heparin Derivatives as Angiogenesis Inhibitors
Current Pharmaceutical Design Therapeutic Applications of Liposomal Based Drug Delivery and Drug Targeting for Immune Linked Inflammatory Maladies: A Contemporary View Point
Current Drug Targets